Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study

By Choi Peter   Farouk Mourad   Manamley Nick   Addison Janet  

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 1007-1017

Springer Publishing Company

Access to resources Recommend Favorite

Switching from Epoetin Alpha to Darbepoetin Alpha in Japanese Hemodialysis Patients: Dose Conversion Ratio

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2008-12 ,pp. : c81-c86

Karger

Access to resources Recommend Favorite

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis

By Hoggard Jeffrey   Crouch Thomas   McMurray Stephen   Levine Michael   Prathikanti Radha   Scarlata Debra   Audhya Paul  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2023-2030

Informa Healthcare

Access to resources Recommend Favorite

The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis

By Abu-Alfa Ali K.   Sloan Lance   Charytan Chaim   Sekkarie Mohamed   Scarlata Debra   Globe Denise   Audhya Paul  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1091-1100

Informa Healthcare

Access to resources Recommend Favorite

Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE

By Pronai Wolfgang   Neyer Ulrich   Barnas Ursula   Wieser Clemens   Jaeger Christine   Dekic Daniel   Hemetsberger Margit   Rosenkranz Alexander R.  

Wiener Medizinische Wochenschrift, Vol. 164, Iss. 5-6, 2014-03 ,pp. : 109-119

Springer Publishing Company

Access to resources Recommend Favorite